New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
November 9, 2009
06:59 EDTAVII
theflyonthewall.com: AVI BioPharma reports Q3 EPS (8c) vs. consensus of (7c)
Reports revenue $6.3M vs. consensus of $4.45M. :theflyonthewall.com



News For AVII From The Last 14 Days
Check below for free stories on AVII the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2012
08:47 EDTAVII
theflyonthewall.com: AVI BioPharma announces positive safety results
AVI BioPharma announced positive safety results from all six dose cohorts in the single ascending dose studies of AVI-6002 and AVI-6003, AVI's lead drug candidates being evaluated for the treatment of Ebola virus and Marburg virus, respectively. AVI is conducting this work under a Department of Defense contract managed by the Joint Project Manager Transformational Medical Technologies (JPM-TMT) Project Management Office. :theflyonthewall.com